Read more

October 28, 2020
1 min read
Save

Top in endocrinology: Testosterone levels, metabolic management

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A recent study found that sociodemographic and lifestyle factors influence testosterone levels in middle-aged men. It was the top story in endocrinology last week.

Another top story was about data that showed metabolic management restores thyroid function in adults with type 2 diabetes.

Testosterone drawing Adobe
Source: Adobe Stock

Read these and more top stories in endocrinology below:

Sociodemographic, lifestyle factors influence testosterone levels in middle-aged men

Providers should consider several modifiable sociodemographic and lifestyle factors when assessing testosterone levels for men aged 40 to 69 years, according to study results published in Clinical Endocrinology. Read more.

Metabolic management restores thyroid function in adults with type 2 diabetes

Adults in China with type 2 diabetes had improved glucose control and a restoration of thyroid function after participating in metabolic management, according to a study published in the Journal of Diabetes. Read more.

Microwave ablation ‘safe and effective technique’ at treating large benign thyroid nodules

A cohort of adults who underwent microwave ablation to treat solid or mostly solid benign thyroid nodules had a mean shrinkage of more than 60% 6 months after the procedure, according to findings published in Clinical Endocrinology. Read more.

Teprotumumab confers long-term benefits in thyroid eye disease

Adults with active thyroid eye disease assigned the human monoclonal antibody teprotumumab (Tepezza, Horizon Therapeutics) experienced improvements in disease outcomes that persisted nearly 1 year after receiving the last trial dose, new study data show. Read more.

FDA issues clarification on insulin pen distribution

The FDA clarified the intent of November 2019 revisions to labeling for insulin pens that state that health care professionals should dispense the pens to a single patient in the original sealed carton. Read more.